Impacts of Interleukin-17 Neutralization on the Inflammatory Response in a Healing Ligament
Received Date: Mar 15, 2017 / Accepted Date: Mar 30, 2017 / Published Date: Apr 06, 2017
In this study, we sought to improve ligament healing by modulating the inflammatory response after acute injury through the neutralization of Interleukin-17 (IL-17), which we hypothesized would decrease inflammatory cell infiltration and cytokine production. Administration of an Interleukin-17 neutralizing antibody (IL-17 NA) immediately following a rat medial collateral ligament (MCL) transection resulted in alterations in inflammatory cell populations and cytokine expression within the healing ligament, but did not reduce inflammation. Specifically, treatment resulted in a decrease in M2 (antiinflammatory) macrophages, an increase in T cells, and an increase in the levels of IL-2, IL-6, and IL-12 in the MCL 7 days post injury. IL-17NA treatment, and subsequent immunomodulation, did not result in improved ligament healing, as measured by collagen composition and wound size.
Keywords: Interleukin-17; Medial collateral ligament; Ligament healing; Immunomodulation
Citation: Clements AEB, Chamberlain CS, Leiferman EM, Murphy WL, Vanderby R (2017) Impacts of Interleukin-17 Neutralization on the Inflammatory Response in a Healing Ligament. J Cytokine Biol 2: 113. Doi: 10.4172/2576-3881.1000113
Copyright: © 2017 Clements AEB et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
- Total views: 2420
- [From(publication date): 0-2017 - May 25, 2022]
- Breakdown by view type
- HTML page views: 2023
- PDF downloads: 397